Correlation Between Fubon MSCI and Level Biotechnology

Can any of the company-specific risk be diversified away by investing in both Fubon MSCI and Level Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fubon MSCI and Level Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fubon MSCI Taiwan and Level Biotechnology, you can compare the effects of market volatilities on Fubon MSCI and Level Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fubon MSCI with a short position of Level Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fubon MSCI and Level Biotechnology.

Diversification Opportunities for Fubon MSCI and Level Biotechnology

-0.76

Correlation Coefficient

Fubon MSCI  Level Biotechnology

Pay attention - limited upside

The 3 months correlation between Fubon and Level is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Fubon MSCI Taiwan and Level Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Level Biotechnology and Fubon MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fubon MSCI Taiwan are associated (or correlated) with Level Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Level Biotechnology has no effect on the direction of Fubon MSCI i.e., Fubon MSCI and Level Biotechnology go up and down completely randomly.

Pair Corralation between Fubon MSCI and Level Biotechnology

Assuming the 90 days trading horizon Fubon MSCI Taiwan is expected to under-perform the Level Biotechnology. In addition to that, Fubon MSCI is 1.77 times more volatile than Level Biotechnology. It trades about -0.12 of its total potential returns per unit of risk. Level Biotechnology is currently generating about 0.16 per unit of volatility. If you would invest  3,185  in Level Biotechnology on December 29, 2024 and sell it today you would earn a total of  210.00  from holding Level Biotechnology or generate 6.59% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Fubon MSCI Taiwan  vs.  Level Biotechnology

Fubon MSCI Taiwan

Risk-Adjusted Performance

Very Weak

Over the last 90 days Fubon MSCI Taiwan has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Etf's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the fund sophisticated investors.

Level Biotechnology

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Level Biotechnology are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Level Biotechnology may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Fubon MSCI and Level Biotechnology

The main advantage of trading using opposite Fubon MSCI and Level Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fubon MSCI position performs unexpectedly, Level Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Level Biotechnology will offset losses from the drop in Level Biotechnology's long position.

The idea behind Fubon MSCI Taiwan and Level Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.